Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ko Fujimori

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
The FEBS Journal|February 9, 2010
Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivoYasushi Fujitani, Kosuke Aritake, Yoshihide Kanaoka, et al.
The Biochemical Journal|January 18, 2012
Lipocalin-type prostaglandin D synthase protects against oxidative stress-induced neuronal cell deathAyano Fukuhara, Mao Yamada, Ko Fujimori, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in IleumNaoki Teno, Yusuke Iguchi, Keisuke Oda, et al.
Bioorganic & Medicinal Chemistry|April 7, 2023
Discovery of FXR/PPARγ dual partial agonistYukiko Yamashita, Keigo Gohda, Yusuke Iguchi, et al.
Bioorganic & Medicinal Chemistry|July 4, 2020
N<sup>1</sup>-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR)Arisa Masuda, Keigo Gohda, Yusuke Iguchi, et al.
Molecular Medicine Reports|July 19, 2025
Differential expression of haematopoietic prostaglandin D synthase by POU2F3‑positive tuft cells in conventional bilayered oncocytic and metaplastic epithelia of Warthin tumoursKenta Hosomi, Akira Sato, Mitsuaki Ishida, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Nonacidic Chemotype Possessing <i>N</i>-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) AntagonistsNaoki Teno, Yukiko Yamashita, Yusuke Iguchi, et al.
Biological & Pharmaceutical Bulletin|July 16, 2025
FLG249 Exhibits FXR Antagonist Activity by Inducing Dissociation of Both Corepressors and Coactivators from FXRYusuke Iguchi, Yukiko Yamashita, Keigo Gohda, et al.
Elife|February 13, 2023
Oligodendrocyte-lineage cell exocytosis and L-type prostaglandin D synthase promote oligodendrocyte development and myelinationLin Pan, Amelia Trimarco, Alice J Zhang, et al.
The Journal of Biological Chemistry|August 24, 2007
NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavityShigeru Shimamoto, Takuya Yoshida, Takashi Inui, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The FEBS Journal|February 9, 2010
Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivoYasushi Fujitani, Kosuke Aritake, Yoshihide Kanaoka, et al.
The Biochemical Journal|January 18, 2012
Lipocalin-type prostaglandin D synthase protects against oxidative stress-induced neuronal cell deathAyano Fukuhara, Mao Yamada, Ko Fujimori, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in IleumNaoki Teno, Yusuke Iguchi, Keisuke Oda, et al.
Bioorganic & Medicinal Chemistry|April 7, 2023
Discovery of FXR/PPARγ dual partial agonistYukiko Yamashita, Keigo Gohda, Yusuke Iguchi, et al.
Bioorganic & Medicinal Chemistry|July 4, 2020
N<sup>1</sup>-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR)Arisa Masuda, Keigo Gohda, Yusuke Iguchi, et al.
Molecular Medicine Reports|July 19, 2025
Differential expression of haematopoietic prostaglandin D synthase by POU2F3‑positive tuft cells in conventional bilayered oncocytic and metaplastic epithelia of Warthin tumoursKenta Hosomi, Akira Sato, Mitsuaki Ishida, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Nonacidic Chemotype Possessing <i>N</i>-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) AntagonistsNaoki Teno, Yukiko Yamashita, Yusuke Iguchi, et al.
Biological & Pharmaceutical Bulletin|July 16, 2025
FLG249 Exhibits FXR Antagonist Activity by Inducing Dissociation of Both Corepressors and Coactivators from FXRYusuke Iguchi, Yukiko Yamashita, Keigo Gohda, et al.
Elife|February 13, 2023
Oligodendrocyte-lineage cell exocytosis and L-type prostaglandin D synthase promote oligodendrocyte development and myelinationLin Pan, Amelia Trimarco, Alice J Zhang, et al.
The Journal of Biological Chemistry|August 24, 2007
NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavityShigeru Shimamoto, Takuya Yoshida, Takashi Inui, et al.
Pageof 9